ID   A2780
AC   CVCL_0134
SY   A-2780; 2780; A2780S; A2780par
DR   BTO; BTO_0002549
DR   CLO; CLO_0001571
DR   EFO; EFO_0006362
DR   MCCL; MCC:0000027
DR   CLDB; cl193
DR   CLDB; cl194
DR   CLDB; cl4894
DR   ABM; T8089
DR   AddexBio; C0017002/20
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0031
DR   BioGRID_ORCS_Cell_line; 329
DR   BioSample; SAMN03472806
DR   BioSample; SAMN10988216
DR   cancercelllines; CVCL_0134
DR   CancerTools; 152706
DR   Cell_Model_Passport; SIDM00210
DR   ChEMBL-Cells; CHEMBL3308421
DR   ChEMBL-Targets; CHEMBL614004
DR   CLS; 300491
DR   Cosmic; 688090
DR   Cosmic; 755844
DR   Cosmic; 849607
DR   Cosmic; 906804
DR   Cosmic; 923108
DR   Cosmic; 948284
DR   Cosmic; 987394
DR   Cosmic; 1093558
DR   Cosmic; 1102819
DR   Cosmic; 1139223
DR   Cosmic; 1198265
DR   Cosmic; 1305309
DR   Cosmic; 1609529
DR   Cosmic; 1707564
DR   Cosmic; 1708387
DR   Cosmic; 1709251
DR   Cosmic; 1945872
DR   Cosmic; 1995331
DR   Cosmic; 2582805
DR   Cosmic; 2674698
DR   Cosmic-CLP; 906804
DR   DepMap; ACH-000657
DR   ECACC; 93112519
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 906804
DR   GEO; GSM184388
DR   GEO; GSM184389
DR   GEO; GSM383925
DR   GEO; GSM503257
DR   GEO; GSM659370
DR   GEO; GSM711722
DR   GEO; GSM827312
DR   GEO; GSM851909
DR   GEO; GSM886853
DR   GEO; GSM887918
DR   GEO; GSM1001419
DR   GEO; GSM1001420
DR   GEO; GSM1001488
DR   GEO; GSM1291126
DR   GEO; GSM1291129
DR   GEO; GSM1340577
DR   GEO; GSM1374380
DR   GEO; GSM1374381
DR   GEO; GSM1669581
DR   GEO; GSM2474971
DR   GEO; GSM4845007
DR   GEO; GSM4845008
DR   GEO; GSM6065211
DR   GEO; GSM6065212
DR   GEO; GSM6065213
DR   Hysigen; TCH-C112
DR   IARC_TP53; 21161
DR   ICLC; HTL98008
DR   LiGeA; CCLE_809
DR   LINCS_LDP; LCL-1518
DR   Lonza; 207
DR   MetaboLights; MTBLS156
DR   MetaboLights; MTBLS1014
DR   NCI-DCTD; A2780
DR   PharmacoDB; A2780_40_2019
DR   PRIDE; PXD001176
DR   PRIDE; PXD003105
DR   PRIDE; PXD003252
DR   PRIDE; PXD003668
DR   PRIDE; PXD013811
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0134
DR   PubChem_Cell_line; CVCL_0134
DR   Wikidata; Q54606559
DR   Ximbio; 152706
RX   PubMed=1348364;
RX   PubMed=1999494;
RX   PubMed=2429947;
RX   PubMed=2751261;
RX   PubMed=3335022;
RX   PubMed=3539322;
RX   PubMed=3986765;
RX   PubMed=6173755;
RX   PubMed=6372095;
RX   PubMed=6954533;
RX   PubMed=7927910;
RX   PubMed=8012063;
RX   PubMed=8557231;
RX   PubMed=9041185;
RX   PubMed=11103784;
RX   PubMed=11416159;
RX   PubMed=12080474;
RX   PubMed=15677628;
RX   PubMed=18273836;
RX   PubMed=19714814;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=22328975;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=28546799;
RX   PubMed=30485824;
RX   PubMed=30894224;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=33287223;
RX   PubMed=34071702;
RX   PubMed=35839778;
RX   PubMed=36476833;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/a2780/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/2/cell-lines-detail-64.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: African American.
CC   Doubling time: 25.3 +- 1 hours (PubMed=3539322); 16 hours (PubMed=25984343); 18.41 hours (JWGray panel).
CC   HLA typing: A*26:03,26:03; B*37:04,49:01; C*02:02,07:01; DQB1*06:07,06:07; DRB1*01:01,01:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15677628; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Pro604Ser (c.1810C>T); ClinVar=VCV000127343; Zygosity=Unspecified (PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu365Lys (c.1093G>A); ClinVar=VCV000419222; Zygosity=Heterozygous (DepMap=ACH-000657).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys128_Arg130del (c.383_391del9); Zygosity=Homozygous (PubMed=25230021; DepMap=ACH-000657).
CC   Sequence variation: Mutation; HGNC; HGNC:17271; RRAS2; Simple; p.Gln72Leu (c.215A>T); ClinVar=VCV000009447; Zygosity=Homozygous (DepMap=ACH-000657).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Glycomics; N-glycan profiling; Lectin array.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=93.08%; Native American=0%; East Asian, North=2.76%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=4.17% (PubMed=30894373).
CC   Discontinued: ECACC; 93112519; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): AddexBio=C0017002/20; Cosmic-CLP=906804; ECACC=93112519; ICLC=HTL98008; PubMed=11416159; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11,12,13 (ICLC=HTL98008)
ST   D16S539: 11,13 (AddexBio=C0017002/20; Cosmic-CLP=906804; ECACC=93112519; PubMed=25230021; PubMed=25877200; PubMed=30485824)
ST   D18S51: 16,18
ST   D19S433: 12
ST   D21S11: 28 (PubMed=25230021; PubMed=25877200)
ST   D21S11: 28,29 (PubMed=30485824)
ST   D2S1338: 21,22
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 15,17
ST   FGA: 19,24
ST   Penta D: 8,9
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 25-06-26; Version: 51
CH   CVCL_C9BP ! 2780AD
CH   CVCL_C3NF ! A2780 LIN28B KO
CH   CVCL_C0D6 ! A2780 PTX(4)
CH   CVCL_E5L2 ! A2780 RRAS2 KO#20
CH   CVCL_E5L1 ! A2780 RRAS2 KO#3
CH   CVCL_H619 ! A2780-1A9
CH   CVCL_ZE22 ! A2780-CBDCA-R
CH   CVCL_H745 ! A2780-cisR
CH   CVCL_EG64 ! A2780-DR
CH   CVCL_4T95 ! A2780-DX1
CH   CVCL_TZ68 ! A2780-M
CH   CVCL_E5I4 ! A2780-NiraR
CH   CVCL_DI16 ! A2780-SCA
CH   CVCL_1F93 ! A2780-TC1
CH   CVCL_7224 ! A2780/100
CH   CVCL_D156 ! A2780/ACR6
CH   CVCL_D157 ! A2780/ACRP
CH   CVCL_B037 ! A2780/AD10
CH   CVCL_D537 ! A2780/ADDP
CH   CVCL_B7S7 ! A2780/C100
CH   CVCL_F638 ! A2780/C200
CH   CVCL_F639 ! A2780/C30
CH   CVCL_B7S6 ! A2780/C300
CH   CVCL_B7S8 ! A2780/C50
CH   CVCL_B7S5 ! A2780/C80
CH   CVCL_D620 ! A2780/CBP
CH   CVCL_D619 ! A2780/CDDP
CH   CVCL_Y180 ! A2780/cDDP
CH   CVCL_A5AB ! A2780/cmv
CH   CVCL_A5PS ! A2780/CP20
CH   CVCL_0135 ! A2780/CP70
CH   CVCL_A5PT ! A2780/CP8
CH   CVCL_A5AC ! A2780/m175
CH   CVCL_A5AD ! A2780/m248
CH   CVCL_A5AE ! A2780/m273
CH   CVCL_4862 ! A2780/R
CH   CVCL_4863 ! A2780/S
CH   CVCL_IJ13 ! A2780/Taxol
CH   CVCL_4V45 ! A2780/TPT
CH   CVCL_UJ39 ! A2780AD
CH   CVCL_1941 ! A2780ADR
CH   CVCL_1942 ! A2780cis
CH   CVCL_UJ38 ! A2780ME
CH   CVCL_C1NE ! A2780veliR
CH   CVCL_F4WH ! HyCyte A2780 stable cell line for hSNCA overexpression
//
RX   PubMed=6173755; DOI=10.1038/295116a0;
RA   Eva, Alessandra
RA   Robbins, Keith Cranston
RA   Andersen, Philip Roger
RA   Srinivasan, Alagarsamy
RA   Tronick, Steven R.
RA   Reddy, E. Premkumar
RA   Ellmore, Nelson Wayne
RA   Galen, Angela T.
RA   Lautenberger, James Allen
RA   Papas, Takis S.
RA   Westin, Eric H.
RA   Wong-Staal, Flossie
RA   Gallo, Robert Charles
RA   Aaronson, Stuart A.
RT   "Cellular genes analogous to retroviral onc genes are transcribed in
RT   human tumour cells.";
RL   Nature 295:116-119(1982).
//
RX   PubMed=7927910; DOI=10.1002/ijc.2910590118;
RA   Huxham, Ian M.
RA   Barlow, Andrew L.
RA   Lewis, Alexander D.
RA   Plumb, Jane
RA   Mairs, Robert J.
RA   Gaze, Mark N.
RA   Workman, Paul
RT   "Differential intracellular processing of the anthracycline drug
RT   ME2303 in doxorubicin-sensitive (A2780) and -resistant (A2780AD) human
RT   ovarian cancer cells as studied with confocal laser scanning
RT   microscopy and image analysis.";
RL   Int. J. Cancer 59:94-102(1994).
//
RX   PubMed=8557231; DOI=10.1006/gyno.1996.0014;
RA   Skilling, Jeffrey S.
RA   Squatrito, Robert C.
RA   Connor, Joseph P.
RA   Niemann, Theodore
RA   Buller, Richard E.
RT   "p53 gene mutation analysis and antisense-mediated growth inhibition
RT   of human ovarian carcinoma cell lines.";
RL   Gynecol. Oncol. 60:72-80(1996).
//
RX   PubMed=3986765;
RA   Louie, Karen Guigere
RA   Behrens, Brent C.
RA   Kinsella, Timothy James
RA   Hamilton, Thomas C.
RA   Grotzinger, Karen R.
RA   McKoy, Wilma M.
RA   Winker, Margaret A.
RA   Ozols, Robert F.
RT   "Radiation survival parameters of antineoplastic drug-sensitive and
RT   -resistant human ovarian cancer cell lines and their modification by
RT   buthionine sulfoximine.";
RL   Cancer Res. 45:2110-2115(1985).
//
RX   PubMed=6372095; DOI=10.1126/science.6372095;
RA   Rogan, Alfred M.
RA   Hamilton, Thomas C.
RA   Young, Robert C.
RA   Klecker, Raymond W. Jr.
RA   Ozols, Robert F.
RT   "Reversal of adriamycin resistance by verapamil in human ovarian
RT   cancer.";
RL   Science 224:994-996(1984).
//
RX   PubMed=31978347; DOI=10.1016/j.cell.2019.12.023; PMCID=PMC7339254;
RA   Nusinow, David Paul
RA   Szpyt, John
RA   Ghandi, Mahmoud
RA   Rose, Christopher M.
RA   McDonald, E. Robert 3rd
RA   Kalocsay, Marian
RA   Jane-Valbuena, Judit
RA   Gelfand, Ellen T.
RA   Schweppe, Devin Karl
RA   Jedrychowski, Mark P.
RA   Golji, Javad
RA   Porter, Dale A.
RA   Rejtar, Tomas
RA   Wang, Y. Karen
RA   Kryukov, Gregory V.
RA   Stegmeier, Frank
RA   Erickson, Brian K.
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RA   Gygi, Steven P.
RT   "Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
RL   Cell 180:387-402.e16(2020).
//
RX   PubMed=12080474; DOI=10.1038/sj.onc.1205542;
RA   Manzano, Ramon G.
RA   Montuenga, Luis M.
RA   Dayton, Mark A.
RA   Dent, Paul
RA   Kinoshita, Ichiro
RA   Vicent, Silvestre
RA   Gardner, Ginger J.
RA   Nguyen, PhuongMai
RA   Choi, Yung-Hyun
RA   Trepel, Jane B.
RA   Auersperg, Nelly
RA   Birrer, Michael J.
RT   "CL100 expression is down-regulated in advanced epithelial ovarian
RT   cancer and its re-expression decreases its malignant potential.";
RL   Oncogene 21:4435-4447(2002).
//
RX   PubMed=1348364; DOI=10.1073/pnas.89.7.3070; PMCID=PMC48805;
RA   Godwin, Andrew Kent
RA   Meister, Alton
RA   O'Dwyer, Peter J.
RA   Huang, Chin-Shiou
RA   Hamilton, Thomas C.
RA   Anderson, Mary E.
RT   "High resistance to cisplatin in human ovarian cancer cell lines is
RT   associated with marked increase of glutathione synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:3070-3074(1992).
//
RX   PubMed=27235858; DOI=10.1016/j.ygyno.2016.05.028; PMCID=PMC4961516;
RA   Hernandez, Lidia
RA   Kim, Marianne K.
RA   Lyle, L. Tiffany
RA   Bunch, Kristen Paige
RA   House, Carrie D.
RA   Ning, Franklin
RA   Noonan, Anne M.
RA   Annunziata, Christina Messineo
RT   "Characterization of ovarian cancer cell lines as in vivo models for
RT   preclinical studies.";
RL   Gynecol. Oncol. 142:332-340(2016).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn, Christiaan
RA   Durinck, Steffen
RA   Stawiski, Eric W.
RA   Haverty, Peter M.
RA   Jiang, Zhao-Shi
RA   Liu, Han-Bin
RA   Degenhardt, Jeremiah
RA   Mayba, Oleg
RA   Gnad, Florian
RA   Liu, Jin-Feng
RA   Pau, Gregoire
RA   Reeder, Jens
RA   Cao, Yi
RA   Mukhyala, Kiran
RA   Selvaraj, Suresh K.
RA   Yu, Ma-Mie
RA   Zynda, Gregory J.
RA   Brauer, Matthew J.
RA   Wu, Thomas D.
RA   Gentleman, Robert Clifford
RA   Manning, Gerard
RA   Yauch, Robert L.
RA   Bourgon, Richard
RA   Stokoe, David
RA   Modrusan, Zora
RA   Neve, Richard M.
RA   de Sauvage, Frederic J.
RA   Settleman, Jeffrey
RA   Seshagiri, Somasekar
RA   Zhang, Ze-Min
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662;
RA   Rothenberg, S. Michael
RA   Mohapatra, Gayatry
RA   Rivera, Miguel N.
RA   Winokur, Daniel
RA   Greninger, Patricia
RA   Nitta, Mai
RA   Sadow, Peter M.
RA   Sooriyakumar, Gaya
RA   Brannigan, Brian W.
RA   Ulman, Matthew J.
RA   Perera, Rushika M.
RA   Wang, Rui
RA   Tam, Angela
RA   Ma, Xiao-Jun
RA   Erlander, Mark
RA   Sgroi, Dennis C.
RA   Rocco, James W.
RA   Lingen, Mark W.
RA   Cohen, Ezra E.W.
RA   Louis, David Neil
RA   Settleman, Jeffrey
RA   Haber, Daniel Arie
RT   "A genome-wide screen for microdeletions reveals disruption of
RT   polarity complex genes in diverse human cancers.";
RL   Cancer Res. 70:2158-2164(2010).
//
RX   PubMed=30894224; DOI=10.1186/s40659-019-0220-0; PMCID=PMC6427839;
RA   Viscarra, Tamara
RA   Buchegger, Kurt
RA   Jofre, Ignacio Andres
RA   Riquelme, Ismael
RA   Zanella, Louise
RA   Abanto Marin, Michel
RA   Parker, Alyssa C.
RA   Piccolo, Stephen R.
RA   Roa, Juan Carlos
RA   Ili, Carmen Gloria
RA   Brebi, Priscilla
RT   "Functional and transcriptomic characterization of
RT   carboplatin-resistant A2780 ovarian cancer cell line.";
RL   Biol. Res. 52:13.1-13.13(2019).
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell, Graham Robert
RA   Greenman, Christopher D.
RA   Davies, Helen R.
RA   Butler, Adam P.
RA   Edkins, Sarah
RA   Andrews, Jenny M.
RA   Buck, Gemma
RA   Chen, Lina
RA   Beare, David
RA   Latimer, Calli
RA   Widaa, Sara
RA   Hinton, Jonathan
RA   Fahey, Ciara
RA   Fu, Bei-Yuan
RA   Swamy, Sajani
RA   Dalgliesh, Gillian L.
RA   Teh, Bin Tean
RA   Deloukas, Panos
RA   Yang, Feng-Tang
RA   Campbell, Peter J.
RA   Futreal, P. Andrew
RA   Stratton, Michael Rudolf
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=3539322;
RA   Behrens, Brent C.
RA   Hamilton, Thomas C.
RA   Masuda, Hidetaka
RA   Grotzinger, Karen R.
RA   Whang-Peng, Jacqueline
RA   Louie, Karen Guigere
RA   Knutsen, Turid
RA   McKoy, Wilma M.
RA   Young, Robert C.
RA   Ozols, Robert F.
RT   "Characterization of a cis-diamminedichloroplatinum(II)-resistant
RT   human ovarian cancer cell line and its use in evaluation of platinum
RT   analogues.";
RL   Cancer Res. 47:414-418(1987).
//
RX   PubMed=25230021; DOI=10.1371/journal.pone.0103988; PMCID=PMC4167545;
RA   Beaufort, Corine M.
RA   Helmijr, Jean C.A.
RA   Piskorz, Anna M.
RA   Hoogstraat, Marlous
RA   Ruigrok-Ritstier, Kirsten
RA   Besselink, Nicolle
RA   Murtaza, Muhammed
RA   van IJcken, Wilfred F.J.
RA   Heine, Anouk A.J.
RA   Smid, Marcel
RA   Koudijs, Marco J.
RA   Brenton, James D.
RA   Berns, Els M.J.J.
RA   Helleman, Jozien
RT   "Ovarian cancer cell line panel (OCCP): clinical importance of in
RT   vitro morphological subtypes.";
RL   PLoS ONE 9:e103988.1-e103988.16(2014).
//
RX   PubMed=27561551; DOI=10.1038/ncomms12645; PMCID=PMC5007461;
RA   Coscia, Fabian
RA   Watters, Karen M.
RA   Curtis, Marion
RA   Eckert, Mark A.
RA   Chiang, Chun-Yi
RA   Tyanova, Stefka
RA   Montag, Anthony
RA   Lastra, Ricardo R.
RA   Lengyel, Ernst Robert
RA   Mann, Matthias
RT   "Integrative proteomic profiling of ovarian cancer cell lines reveals
RT   precursor cell associated proteins and functional status.";
RL   Nat. Commun. 7:12645.1-12645.14(2016).
//
RX   PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652;
RA   Cowley, Glenn S.
RA   Weir, Barbara A.
RA   Vazquez, Francisca
RA   Tamayo, Pablo
RA   Scott, Justine A.
RA   Rusin, Scott
RA   East-Seletsky, Alexandra
RA   Ali, Levi D.
RA   Gerath, William F.J.
RA   Pantel, Sarah E.
RA   Lizotte, Patrick Hall
RA   Jiang, Guo-Zhi
RA   Hsiao, Jessica
RA   Tsherniak, Aviad
RA   Dwinell, Elizabeth
RA   Aoyama, Simon
RA   Okamoto, Michael
RA   Harrington, William
RA   Gelfand, Ellen T.
RA   Green, Thomas M.
RA   Tomko, Mark J.
RA   Gopal, Shuba
RA   Wong, Terence C.
RA   Li, Hu-Bo
RA   Howell, Sara
RA   Stransky, Nicolas
RA   Liefeld, Ted
RA   Jang, Dongkeun
RA   Bistline, Jonathan
RA   Meyers, Barbara Hill
RA   Armstrong, Scott Allen
RA   Anderson, Kenneth Carl
RA   Stegmaier, Kimberly
RA   Reich, Michael
RA   Pellman, David
RA   Boehm, Jesse S.
RA   Mesirov, Jill P.
RA   Golub, Todd Robert
RA   Root, David E.
RA   Hahn, William Chun
RT   "Parallel genome-scale loss of function screens in 216 cancer cell
RT   lines for the identification of context-specific genetic
RT   dependencies.";
RL   Sci. Data 1:140035.1-140035.12(2014).
//
RX   PubMed=11416159; DOI=10.1073/pnas.121616198; PMCID=PMC35459;
RA   Masters, John R.W.
RA   Thomson, Jim A.
RA   Daly-Burns, Bernadette
RA   Reid, Yvonne A.
RA   Dirks, Wilhelm Gerhard
RA   Packer, Phil
RA   Toji, Lorraine Hellenga
RA   Ohno, Tadao
RA   Tanabe, Hideyuki
RA   Arlett, Colin Francis
RA   Kelland, Lloyd R.
RA   Harrison, Maureen
RA   Virmani, Arvind K.
RA   Ward, Timothy H.
RA   Ayres, Karen L.
RA   Debenham, Paul G.
RT   "Short tandem repeat profiling provides an international reference
RT   standard for human cell lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001).
//
RX   PubMed=3335022;
RA   Alley, Michael Curtis
RA   Scudiero, Dominic A.
RA   Monks, Anne
RA   Hursey, Miriam L.
RA   Czerwinski, Maciej J.
RA   Fine, Donald L.
RA   Abbott, Betty Jane
RA   Mayo, Joseph G.
RA   Shoemaker, Robert H.
RA   Boyd, Michael R.
RT   "Feasibility of drug screening with panels of human tumor cell lines
RT   using a microculture tetrazolium assay.";
RL   Cancer Res. 48:589-601(1988).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076;
RA   Li, Jun
RA   Zhao, Wei
RA   Akbani, Rehan
RA   Liu, Wen-Bin
RA   Ju, Zhen-Lin
RA   Ling, Shi-Yun
RA   Vellano, Christopher P.
RA   Roebuck, Paul
RA   Yu, Qing-Hua
RA   Eterovic, Agda Karina
RA   Byers, Lauren Averett
RA   Davies, Michael A.
RA   Deng, Wan-Leng
RA   Gopal, Y.N. Vashisht
RA   Chen, Guo
RA   von Euw, Erika Maria
RA   Slamon, Dennis Joseph
RA   Conklin, Dylan
RA   Heymach, John Victor
RA   Gazdar, Adi F.
RA   Minna, John D.
RA   Myers, Jeffrey N.
RA   Lu, Yi-Ling
RA   Mills, Gordon B.
RA   Liang, Han
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   PubMed=22585861; DOI=10.1158/2159-8290.CD-11-0224; PMCID=PMC5057396;
RA   Marcotte, Richard
RA   Brown, Kevin R.
RA   Suarez Saiz, Fernando Jose
RA   Sayad, Azin
RA   Karamboulas, Konstantina
RA   Krzyzanowski, Paul M.
RA   Sircoulomb, Fabrice
RA   Medrano, Mauricio
RA   Fedyshyn, Yaroslav
RA   Koh, Judice Lie-Yong
RA   van Dyk, Dewald
RA   Fedyshyn, Bohdana
RA   Luhova, Marianna
RA   Brito, Glauber C.
RA   Vizeacoumar, Franco J.
RA   Vizeacoumar, Frederick S.
RA   Datti, Alessandro
RA   Kasimer, Dahlia
RA   Buzina, Alla
RA   Mero, Patricia
RA   Misquitta, Christine
RA   Normand, Josee
RA   Haider, Maliha
RA   Ketela, Troy
RA   Wrana, Jeffrey L.
RA   Rottapel, Robert
RA   Neel, Benjamin G.
RA   Moffat, Jason
RT   "Essential gene profiles in breast, pancreatic, and ovarian cancer
RT   cells.";
RL   Cancer Discov. 2:172-189(2012).
//
RX   PubMed=6954533; DOI=10.1073/pnas.79.7.2194; PMCID=PMC346157;
RA   Westin, Eric H.
RA   Gallo, Robert Charles
RA   Arya, Suresh K.
RA   Eva, Alessandra
RA   Souza, Lawrence M.
RA   Baluda, Marcel Albert
RA   Aaronson, Stuart A.
RA   Wong-Staal, Flossie
RT   "Differential expression of the amv gene in human hematopoietic
RT   cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:2194-2198(1982).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675;
RA   Dutil, Julie
RA   Chen, Zhi-Hua
RA   Monteiro, Alvaro N.A.
RA   Teer, Jamie K.
RA   Eschrich, Steven A.
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=36476833; DOI=10.1038/s41388-022-02563-9; PMCID=PMC9883167;
RA   Clavain, Laura
RA   Fernandez-Pisonero, Maria Isabel
RA   Movilla, Nieves
RA   Lorenzo-Martin, Luis Francisco
RA   Nieto, Blanca
RA   Abad, Antonio
RA   Garcia-Navas, Rosula
RA   Llorente-Gonzalez, Clara
RA   Sanchez-Martin, Manuel
RA   Vicente-Manzanares, Miguel
RA   Santos, Eugenio
RA   Alarcon, Balbino
RA   Garcia-Aznar, Jose Manuel
RA   Dosil, Mercedes
RA   Bustelo, Xose R.
RT   "Characterization of mutant versions of the R-RAS2/TC21 GTPase found
RT   in tumors.";
RL   Oncogene 42:389-405(2023).
//
RX   PubMed=22328975; DOI=10.1158/2159-8290.CD-11-0170; PMCID=PMC3274821;
RA   Hanrahan, Aphrothiti J.
RA   Schultz, Nikolaus
RA   Westfal, Maggie L.
RA   Sakr, Rita A.
RA   Giri, Dilip D.
RA   Scarperi, Stefano
RA   Janakiraman, Manickam
RA   Olvera, Narciso
RA   Stevens, Ellen V.
RA   She, Qing-Bai
RA   Aghajanian, Carol
RA   King, Tari Ann
RA   de Stanchina, Elisa
RA   Spriggs, David R.
RA   Heguy, Adriana
RA   Taylor, Barry Stephen
RA   Sander, Chris
RA   Rosen, Neal
RA   Levine, Douglas A.
RA   Solit, David B.
RT   "Genomic complexity and AKT dependence in serous ovarian cancer.";
RL   Cancer Discov. 2:56-67(2012).
//
RX   PubMed=25846456; DOI=10.3892/ijo.2015.2951;
RA   Takenaka, Masataka
RA   Saito, Motonobu
RA   Iwakawa, Reika
RA   Yanaihara, Nozomu
RA   Saito, Misato
RA   Kato, Mamoru
RA   Ichikawa, Hitoshi
RA   Shibata, Tatsuhiro
RA   Yokota, Jun
RA   Okamoto, Aikou
RA   Kohno, Takashi
RT   "Profiling of actionable gene alterations in ovarian cancer by
RT   targeted deep sequencing.";
RL   Int. J. Oncol. 46:2389-2398(2015).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103;
RA   Ghandi, Mahmoud
RA   Huang, Franklin W.
RA   Jane-Valbuena, Judit
RA   Kryukov, Gregory V.
RA   Lo, Christopher C.
RA   McDonald, E. Robert 3rd
RA   Barretina, Jordi Ginesta
RA   Gelfand, Ellen T.
RA   Bielski, Craig M.
RA   Li, Hao-Xin
RA   Hu, Kevin
RA   Andreev-Drakhlin, Alexander Y.
RA   Kim, Jaegil
RA   Hess, Julian M.
RA   Haas, Brian J.
RA   Aguet, Francois
RA   Weir, Barbara A.
RA   Rothberg, Michael V.
RA   Paolella, Brenton R.
RA   Lawrence, Michael Scott
RA   Akbani, Rehan
RA   Lu, Yi-Ling
RA   Tiv, Hong L.
RA   Gokhale, Prafulla C.
RA   de Weck, Antoine
RA   Mansour, Ali Amin
RA   Oh, Coyin
RA   Shih, Juliann
RA   Hadi, Kevin
RA   Rosen, Yanay
RA   Bistline, Jonathan
RA   Venkatesan, Kavitha
RA   Reddy, Anupama
RA   Sonkin, Dmitriy
RA   Liu, Manway
RA   Lehar, Joseph
RA   Korn, Joshua M.
RA   Porter, Dale A.
RA   Jones, Michael D.
RA   Golji, Javad
RA   Caponigro, Giordano
RA   Taylor, Jordan E.
RA   Dunning, Caitlin M.
RA   Creech, Amanda L.
RA   Warren, Allison C.
RA   McFarland, James M.
RA   Zamanighomi, Mahdi
RA   Kauffmann, Audrey
RA   Stransky, Nicolas
RA   Imielinski, Marcin
RA   Maruvka, Yosef E.
RA   Cherniack, Andrew D.
RA   Tsherniak, Aviad
RA   Vazquez, Francisca
RA   Jaffe, Jacob D.
RA   Lane, Andrew Alan
RA   Weinstock, David M.
RA   Johannessen, Cory M.
RA   Morrissey, Michael P.
RA   Stegmeier, Frank
RA   Schlegel, Robert
RA   Hahn, William Chun
RA   Getz, Gad
RA   Mills, Gordon B.
RA   Boehm, Jesse S.
RA   Golub, Todd Robert
RA   Garraway, Levi Alexander
RA   Sellers, William Raj
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017; PMCID=PMC4967469;
RA   Iorio, Francesco
RA   Knijnenburg, Theo A.
RA   Vis, Daniel J.
RA   Bignell, Graham Robert
RA   Menden, Michael Patrick
RA   Schubert, Michael
RA   Aben, Nanne
RA   Goncalves, Emanuel
RA   Barthorpe, Syd
RA   Lightfoot, Howard
RA   Cokelaer, Thomas
RA   Greninger, Patricia
RA   van Dyk, Ewald
RA   Chang, Han
RA   de Silva, Heshani
RA   Heyn, Holger
RA   Deng, Xian-Ming
RA   Egan, Regina K.
RA   Liu, Qing-Song
RA   Mironenko, Tatiana
RA   Mitropoulos, Xeni
RA   Richardson, Laura
RA   Wang, Jin-Hua
RA   Zhang, Ting-Hu
RA   Moran, Sebastian
RA   Sayols, Sergi
RA   Soleimani, Maryam
RA   Tamborero, David
RA   Lopez-Bigas, Nuria
RA   Ross-Macdonald, Petra
RA   Esteller, Manel
RA   Gray, Nathanael S.
RA   Haber, Daniel Arie
RA   Stratton, Michael Rudolf
RA   Benes, Cyril Henri
RA   Wessels, Lodewyk F.A.
RA   Saez-Rodriguez, Julio
RA   McDermott, Ultan
RA   Garnett, Mathew J.
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=8012063;
RA   Cimoli, Guido
RA   Valenti, Monica
RA   Parodi, Silvio
RA   Mazzoni, Alessandra
RA   De Sessa, Fabio
RA   Conte, PierFranco
RA   Russo, Patrizia
RT   "Reversal of 'atypical'-multidrug resistance by recombinant human
RT   tumor necrosis factor in the human ovarian cancer cell line
RT   A2780-DX3.";
RL   Oncol. Res. 5:311-323(1993).
//
RX   PubMed=1999494; DOI=10.1172/JCI115080; PMCID=PMC329864;
RA   Parker, Ricardo J.
RA   Eastman, Alan
RA   Bostick-Bruton, Frieda
RA   Reed, Eddie
RT   "Acquired cisplatin resistance in human ovarian cancer cells is
RT   associated with enhanced repair of cisplatin-DNA lesions and reduced
RT   drug accumulation.";
RL   J. Clin. Invest. 87:772-777(1991).
//
RX   PubMed=28546799; DOI=10.1186/s12014-017-9155-z; PMCID=PMC5442857;
RA   Zhao, Ran
RA   Qin, Wen-Jun
RA   Qin, Rui-Huan
RA   Han, Jing
RA   Li, Can
RA   Wang, Yi-Sheng
RA   Xu, Cong-Jian
RT   "Lectin array and glycogene expression analyses of ovarian cancer cell
RT   line A2780 and its cisplatin-resistant derivate cell line A2780-cp.";
RL   Clin. Proteomics 14:20.1-20.10(2017).
//
RX   PubMed=28273451; DOI=10.1016/j.celrep.2017.02.028;
RA   Medrano, Mauricio
RA   Communal, Laudine
RA   Brown, Kevin R.
RA   Iwanicki, Marcin
RA   Normand, Josee
RA   Paterson, Joshua
RA   Sircoulomb, Fabrice
RA   Krzyzanowski, Paul M.
RA   Novak, Marian
RA   Doodnauth, Sasha A.
RA   Suarez Saiz, Fernando Jose
RA   Cullis, Jane
RA   Al-awar, Rima
RA   Neel, Benjamin G.
RA   McPherson, John
RA   Drapkin, Ronny I.
RA   Ailles, Laurie
RA   Mes-Masson, Anne-Marie
RA   Rottapel, Robert
RT   "Interrogation of functional cell-surface markers identifies CD151
RT   dependency in high-grade serous ovarian cancer.";
RL   Cell Rep. 18:2343-2358(2017).
//
RX   PubMed=24023729; DOI=10.1371/journal.pone.0072162; PMCID=PMC3762837;
RA   Anglesio, Michael S.
RA   Wiegand, Kimberly C.
RA   Melnyk, Nataliya
RA   Chow, Christine
RA   Salamanca, Clara M.
RA   Prentice, Leah M.
RA   Senz, Janine
RA   Yang, Winnie
RA   Spillman, Monique Ann
RA   Cochrane, Dawn R.
RA   Shumansky, Karey
RA   Shah, Sohrab P.
RA   Kalloger, Steve E.
RA   Huntsman, David G.
RT   "Type-specific cell line models for type-specific ovarian cancer
RT   research.";
RL   PLoS ONE 8:e72162.1-e72162.13(2013).
//
RX   PubMed=18273836; DOI=10.1002/gcc.20547;
RA   Prasad, Mona
RA   Bernardini, Marcus
RA   Tsalenko, Anya
RA   Marrano, Paula
RA   Paderova, Jana
RA   Lee, Chung-Hae
RA   Ben-Dor, Amir
RA   Barrett, Michael T.
RA   Squire, Jeremy Andrew
RT   "High definition cytogenetics and oligonucleotide aCGH analyses of
RT   cisplatin-resistant ovarian cancer cells.";
RL   Genes Chromosomes Cancer 47:427-436(2008).
//
RX   PubMed=2429947; DOI=10.20772/cancersci1985.77.9_941;
RA   Tsuruo, Takashi
RA   Hamilton, Thomas C.
RA   Louie, Karen Guigere
RA   Behrens, Brent C.
RA   Young, Robert C.
RA   Ozols, Robert F.
RT   "Collateral susceptibility of adriamycin-, melphalan- and
RT   cisplatin-resistant human ovarian tumor cells to bleomycin.";
RL   Jpn. J. Cancer Res. 77:941-945(1986).
//
RX   PubMed=20204287; DOI=10.3892/or_00000728; PMCID=PMC2909445;
RA   Langland, Gregory T.
RA   Yannone, Steven M.
RA   Langland, Rachel A.
RA   Nakao, Aki
RA   Guan, Ying-Hui
RA   Long, Sydney B.T.
RA   Vonguyen, Lien
RA   Chen, David J.
RA   Gray, Joe W.
RA   Chen, Fan-Qing
RT   "Radiosensitivity profiles from a panel of ovarian cancer cell lines
RT   exhibiting genetic alterations in p53 and disparate DNA-dependent
RT   protein kinase activities.";
RL   Oncol. Rep. 23:1021-1026(2010).
//
RX   PubMed=19714814; DOI=10.1021/pr800856b;
RA   Cicchillitti, Lucia
RA   Di Michele, Michela
RA   Urbani, Andrea
RA   Ferlini, Cristiano
RA   Donati, Maria Benedetta
RA   Scambia, Giovanni
RA   Rotilio, Domenico
RT   "Comparative proteomic analysis of paclitaxel sensitive A2780
RT   epithelial ovarian cancer cell line and its resistant counterpart
RT   A2780TC1 by 2D-DIGE: the role of ERp57.";
RL   J. Proteome Res. 8:1902-1912(2009).
//
RX   PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027;
RA   Barretina, Jordi Ginesta
RA   Caponigro, Giordano
RA   Stransky, Nicolas
RA   Venkatesan, Kavitha
RA   Margolin, Adam A.
RA   Kim, Sungjoon
RA   Wilson, Christopher J.
RA   Lehar, Joseph
RA   Kryukov, Gregory V.
RA   Sonkin, Dmitriy
RA   Reddy, Anupama
RA   Liu, Manway
RA   Murray, Lauren
RA   Berger, Michael F.
RA   Monahan, John E.
RA   Morais, Paula
RA   Meltzer, Jodi
RA   Korejwa, Adam
RA   Jane-Valbuena, Judit
RA   Mapa, Felipa A.
RA   Thibault, Joseph
RA   Bric-Furlong, Eva
RA   Raman, Pichai
RA   Shipway, Aaron
RA   Engels, Ingo H.
RA   Cheng, Jill
RA   Yu, Guo-Ying K.
RA   Yu, Jian-Jun
RA   Aspesi, Peter Jr.
RA   de Silva, Melanie
RA   Jagtap, Kalpana
RA   Jones, Michael D.
RA   Wang, Li
RA   Hatton, Charles
RA   Palescandolo, Emanuele
RA   Gupta, Supriya
RA   Mahan, Scott
RA   Sougnez, Carrie
RA   Onofrio, Robert C.
RA   Liefeld, Ted
RA   MacConaill, Laura Eleanor
RA   Winckler, Wendy
RA   Reich, Michael
RA   Li, Nan-Xin
RA   Mesirov, Jill P.
RA   Gabriel, Stacey B.
RA   Getz, Gad
RA   Ardlie, Kristin
RA   Chan, Vivien
RA   Myer, Vic E.
RA   Weber, Barbara L.
RA   Porter, Jeff
RA   Warmuth, Markus
RA   Finan, Peter
RA   Harris, Jennifer L.
RA   Meyerson, Matthew Langer
RA   Golub, Todd Robert
RA   Morrissey, Michael P.
RA   Sellers, William Raj
RA   Schlegel, Robert
RA   Garraway, Levi Alexander
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=27141528; DOI=10.1016/j.dib.2016.04.001; PMCID=PMC4838930;
RA   Masuishi, Yusuke
RA   Kimura, Yayoi
RA   Arakawa, Noriaki
RA   Hirano, Hisashi
RT   "Data for identification of GPI-anchored peptides and omega-sites in
RT   cancer cell lines.";
RL   Data Brief 7:1302-1305(2016).
//
RX   PubMed=26972028; DOI=10.1016/j.jprot.2016.03.008;
RA   Masuishi, Yusuke
RA   Kimura, Yayoi
RA   Arakawa, Noriaki
RA   Hirano, Hisashi
RT   "Identification of glycosylphosphatidylinositol-anchored proteins and
RT   omega-sites using TiO2-based affinity purification followed by
RT   hydrogen fluoride treatment.";
RL   J. Proteomics 139:77-83(2016).
//
RX   PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010; PMCID=PMC9387775;
RA   Goncalves, Emanuel
RA   Poulos, Rebecca C.
RA   Cai, Zhao-Xiang
RA   Barthorpe, Syd
RA   Manda, Srikanth S.
RA   Lucas, Natasha
RA   Beck, Alexandra
RA   Bucio-Noble, Daniel
RA   Dausmann, Michael
RA   Hall, Caitlin
RA   Hecker, Michael
RA   Koh, Jennifer
RA   Lightfoot, Howard
RA   Mahboob, Sadia
RA   Mali, Iman
RA   Morris, James
RA   Richardson, Laura
RA   Seneviratne, Akila J.
RA   Shepherd, Rebecca
RA   Sykes, Erin
RA   Thomas, Frances
RA   Valentini, Sara
RA   Williams, Steven G.
RA   Wu, Yang-Xiu
RA   Xavier, Dylan
RA   MacKenzie, Karen L.
RA   Hains, Peter G.
RA   Tully, Brett
RA   Robinson, Phillip James
RA   Zhong, Qing
RA   Garnett, Mathew J.
RA   Reddel, Roger Robert
RT   "Pan-cancer proteomic map of 949 human cell lines.";
RL   Cancer Cell 40:835-849.e8(2022).
//
RX   PubMed=9041185;
RA   Johnson, Steven W.
RA   Laub, Paul B.
RA   Beesley, Jacqueline S.
RA   Ozols, Robert F.
RA   Hamilton, Thomas C.
RT   "Increased platinum-DNA damage tolerance is associated with cisplatin
RT   resistance and cross-resistance to various chemotherapeutic agents in
RT   unrelated human ovarian cancer cell lines.";
RL   Cancer Res. 57:850-856(1997).
//
RX   PubMed=2751261;
RA   Mazzoni, Alessandra
RA   Trave, Fabio
RA   Canti, Gianfranco
RA   Franco, Paola
RT   "Effect of the tiapamil analog RO11-2933 on cellular sensitivity to
RT   antitumor drugs in sensitive and multidrug resistant human ovarian
RT   cancer cells.";
RL   Anticancer Res. 9:367-371(1989).
//
RX   PubMed=23839242; DOI=10.1038/ncomms3126; PMCID=PMC3715866;
RA   Domcke, Silvia
RA   Sinha, Rileen
RA   Levine, Douglas A.
RA   Sander, Chris
RA   Schultz, Nikolaus
RT   "Evaluating cell lines as tumour models by comparison of genomic
RT   profiles.";
RL   Nat. Commun. 4:2126.1-2126.10(2013).
//
RX   PubMed=30485824; DOI=10.1016/j.celrep.2018.10.096; PMCID=PMC6481945;
RA   Papp, Eniko
RA   Hallberg, Dorothy
RA   Konecny, Gottfried E.
RA   Bruhm, Daniel C.
RA   Adleff, Vilmos
RA   Noe, Michael
RA   Kagiampakis, Ioannis
RA   Palsgrove, Doreen
RA   Conklin, Dylan
RA   Kinose, Yasuto
RA   White, James R.
RA   Press, Michael Frederick
RA   Drapkin, Ronny I.
RA   Easwaran, Hariharan
RA   Baylin, Stephen Bruce
RA   Slamon, Dennis Joseph
RA   Velculescu, Victor E.
RA   Scharpf, Robert B.
RT   "Integrated genomic, epigenomic, and expression analyses of ovarian
RT   cancer cell lines.";
RL   Cell Rep. 25:2617-2633(2018).
//
RX   PubMed=30971826; DOI=10.1038/s41586-019-1103-9;
RA   Behan, Fiona M.
RA   Iorio, Francesco
RA   Picco, Gabriele
RA   Goncalves, Emanuel
RA   Beaver, Charlotte M.
RA   Migliardi, Giorgia
RA   Santos, Rita
RA   Rao, Yanhua
RA   Sassi, Francesco
RA   Pinnelli, Marika
RA   Ansari, Rizwan
RA   Harper, Sarah
RA   Jackson, David Adam
RA   McRae, Rebecca
RA   Pooley, Rachel
RA   Wilkinson, Piers
RA   van der Meer, Dieudonne J.
RA   Dow, David
RA   Buser-Doepner, Carolyn A.
RA   Bertotti, Andrea
RA   Trusolino, Livio
RA   Stronach, Euan Alexander
RA   Saez-Rodriguez, Julio
RA   Yusa, Kosuke
RA   Garnett, Mathew J.
RT   "Prioritization of cancer therapeutic targets using CRISPR-Cas9
RT   screens.";
RL   Nature 568:511-516(2019).
//
RX   PubMed=22710073; DOI=10.1016/j.ygyno.2012.06.017; PMCID=PMC3432677;
RA   Korch, Christopher T.
RA   Spillman, Monique Ann
RA   Jackson, Twila A.
RA   Jacobsen, Britta M.
RA   Murphy, Susan K.
RA   Lessey, Bruce Arthur
RA   Jordan, Virgil Craig
RA   Bradford, Andrew Peter
RT   "DNA profiling analysis of endometrial and ovarian cell lines reveals
RT   misidentification, redundancy and contamination.";
RL   Gynecol. Oncol. 127:241-248(2012).
//
RX   PubMed=22705003; DOI=10.1016/j.humpath.2012.03.011;
RA   Rahman, Munmun
RA   Nakayama, Kentaro
RA   Rahman, Mohammed Tanjimur
RA   Nakayama, Naomi
RA   Ishikawa, Masako
RA   Katagiri, Atsuko
RA   Iida, Kouji
RA   Nakayama, Satoru
RA   Otsuki, Yoshiro
RA   Shih, Ie-Ming
RA   Miyazaki, Kohji
RT   "Clinicopathologic and biological analysis of PIK3CA mutation in
RT   ovarian clear cell carcinoma.";
RL   Hum. Pathol. 43:2197-2206(2012).
//
RX   PubMed=11103784;
RA   Hough, Colleen D.
RA   Sherman-Baust, Cheryl A.
RA   Pizer, Ellen S.
RA   Montz, Fredrick John
RA   Im, Dwight D.
RA   Rosenshein, Neil B.
RA   Cho, Kathleen R.
RA   Riggins, Gregory J.
RA   Morin, Patrice J.
RT   "Large-scale serial analysis of gene expression reveals genes
RT   differentially expressed in ovarian cancer.";
RL   Cancer Res. 60:6281-6287(2000).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu, Ma-Mie
RA   Selvaraj, Suresh K.
RA   Liang-Chu, May M.Y.
RA   Aghajani, Sahar
RA   Busse, Matthew
RA   Yuan, Jean
RA   Lee, Genee
RA   Peale, Franklin V.
RA   Klijn, Christiaan
RA   Bourgon, Richard
RA   Kaminker, Joshua S.
RA   Neve, Richard M.
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=33287223; DOI=10.3390/ijms21239218; PMCID=PMC7730278;
RA   Szenajch, Jolanta
RA   Szabelska-Beresewicz, Alicja
RA   Swiercz, Aleksandra
RA   Zyprych-Walczak, Joanna
RA   Siatkowski, Idzi
RA   Goralski, Michal
RA   Synowiec, Agnieszka
RA   Handschuh, Luiza
RT   "Transcriptome remodeling in gradual development of inverse resistance
RT   between paclitaxel and cisplatin in ovarian cancer cells.";
RL   Int. J. Mol. Sci. 21:9218.1-9218.30(2020).
//
RX   PubMed=23415752; DOI=10.1016/j.molonc.2012.12.007; PMCID=PMC4106023;
RA   Stordal, Britta
RA   Timms, Kirsten
RA   Farrelly, Angela
RA   Gallagher, Danielle
RA   Busschots, Steven
RA   Renaud, Mickael
RA   Thery, Julien
RA   Williams, Deborah
RA   Potter, Jennifer
RA   Tran, Thanh
RA   Korpanty, Greg
RA   Cremona, Mattia
RA   Carey, Mark S.
RA   Li, Jie
RA   Li, Yang
RA   Aslan, Ozlem
RA   O'Leary, John J.
RA   Mills, Gordon B.
RA   Hennessy, Bryan T.
RT   "BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one
RT   functionally deleterious BRCA1 mutation.";
RL   Mol. Oncol. 7:567-579(2013).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878;
RA   Scholtalbers, Jelle
RA   Boegel, Sebastian
RA   Bukur, Thomas
RA   Byl, Marius
RA   Goerges, Sebastian
RA   Sorn, Patrick
RA   Loewer, Martin
RA   Sahin, Ugur
RA   Castle, John C.
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//
RX   PubMed=15677628; DOI=10.1093/carcin/bgi032;
RA   Gorringe, Kylie Louise
RA   Chin, Suet-Feung
RA   Pharoah, Paul D.P.
RA   Staines, Joanne M.
RA   Oliveira, Carla
RA   Edwards, Paul A.W.
RA   Caldas, Carlos
RT   "Evidence that both genetic instability and selection contribute to
RT   the accumulation of chromosome alterations in cancer.";
RL   Carcinogenesis 26:923-930(2005).
//
RX   PubMed=34071702; DOI=10.3390/ijms22115814; PMCID=PMC8198185;
RA   Golan Berman, Hadar
RA   Chauhan, Pooja
RA   Shalev, Shira
RA   Hassanain, Hiba
RA   Parnas, Avital
RA   Adar, Sheera
RT   "Genomic characterization of cisplatin response uncovers priming of
RT   cisplatin-induced genes in a resistant cell line.";
RL   Int. J. Mol. Sci. 22:5814.1-5814.14(2021).
//